Delivery Order SPE2DB24D1104-SPE2DB24FYAX4

Award Date 7/29/24
Potential Completion Date 7/30/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,135.65 firm fixed-price contract is for the delivery of 100 units of the prescription medication Vyvanse 50 mg capsules. The contract has a performance period ending on June 24, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $6,120.52 firm fixed-price contract is for the supply of Vyvanse 50mg capsules, a prescription medication. The ultimate completion date is September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award is a delivery order with a firm fixed price awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award, valued at $1,502.56, is for the supply of Vyvanse 50 mg capsules. The contract has an ultimate completion date of July 2, 2025 and does not use a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 100 units of the prescription medication Vyvanse 50 mg capsules. The $3,137.16 firm-fixed-price contract has a completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Vyvanse 50 mg capsules. The $1,021.25 firm fixed price contract has an ultimate completion date of March 12, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Vyvanse 20 mg capsules. The contract has a firm fixed price of $1,724.00 and an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,853.40, is for the supply of Vyvanse 50 mg capsules in quantities of 100s. The contract has a firm fixed price pricing type and an ultimate completion date of January 2, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,668.79 firm fixed-price contract is for the supply of 4,565,918,548 units of Vyvanse 50 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide 4,563,336,729 units of the medication Vyvanse 50 mg capsules. The contract has a firm fixed price of $1,948.94 and a completion date of January 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $5,436.94, is for the supply of Vyvanse 50 mg capsules. It is a firm-fixed-price contract with a period of performance through March 18, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYAX4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,975.52 firm-fixed-price contract is for the delivery of Vyvanse 50 mg capsules. The contract has an ultimate completion date of July 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical division, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract was not set aside for any specific business type.

Generated 10/28/24, 9:55 AM